Cost Curve News - News - https://www.costcurvenews.com/blog/page/4/

Fifteen More Drugs Will Get Price Controls Next Month. Here’s How to Prepare

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Putting All of the Pharm-to-Table Resources in One Place

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

PBMs Are Trying to Sell CMS on a ‘Splashy Announcement’ That PBMs Will (Voluntarily) Do the Right Thing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

A New Antibiotic Might Make for the Most Interesting Pricing Story of the Year

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Injected Versions of Cancer Meds Make Life Easier for Patients and Drive Savings for Clinicians. There Is a Backlash Anyway

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Fifteen More Drugs Will Get Price Controls Next Month. Here’s How to Prepare

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

PBMs Are Trying to Sell CMS on a ‘Splashy Announcement’ That PBMs Will (Voluntarily) Do the Right Thing

A New Antibiotic Might Make for the Most Interesting Pricing Story of the Year

Injected Versions of Cancer Meds Make Life Easier for Patients and Drive Savings for Clinicians. There Is a Backlash Anyway

Latest Posts

When Will CMS Publish the Next Set of ‘Negotiated’ Prices for Medicare?

Why a New Drug Just Entered the Market With a List Price One-Tenth of Its Rival

The Five Most Interesting Things Lilly’s Dave Ricks Said on the Cheeky Pint Pod

The Obesity Pricing Paradigm Gets Even More Complex With Novo’s $199 Wegovy Offer

CMS Is About to Announce ‘Negotiated’ Prices on 15 More Medicines. Here’s What the Companies Involved Have Said About Those Prices

Popular

When Will CMS Publish the Next Set of ‘Negotiated’ Prices for Medicare?

Why a New Drug Just Entered the Market With a List Price One-Tenth of Its Rival

The Five Most Interesting Things Lilly’s Dave Ricks Said on the Cheeky Pint Pod

The Obesity Pricing Paradigm Gets Even More Complex With Novo’s $199 Wegovy Offer

CMS Is About to Announce ‘Negotiated’ Prices on 15 More Medicines. Here’s What the Companies Involved Have Said About Those Prices

Coming Soon to a Pharmacy Near You: Big List Price Cuts on Blockbuster Drugs

Latest News

When Will CMS Publish the Next Set of ‘Negotiated’ Prices for Medicare?

Why a New Drug Just Entered the Market With a List Price One-Tenth of Its Rival

Subcribe To Newsletter